Tezepelumab
Modify Date: 2025-08-25 21:49:36
Tezepelumab structure
|
Common Name | Tezepelumab | ||
|---|---|---|---|---|
| CAS Number | 1572943-04-4 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of TezepelumabTezepelumab (AMG 157) is human monoclonal antibody (IgG2λ) that binds specifically to TSLP, blocking it from interacting with its heterodimeric receptor. Tezepelumab can be used for the research of severe, uncontrolled asthma[1]. |
| Name | Tezepelumab |
|---|
| Description | Tezepelumab (AMG 157) is human monoclonal antibody (IgG2λ) that binds specifically to TSLP, blocking it from interacting with its heterodimeric receptor. Tezepelumab can be used for the research of severe, uncontrolled asthma[1]. |
|---|---|
| Related Catalog | |
| Target |
TSLP[1] |
| In Vitro | Tezepelumab 阻断胸腺基质淋巴细胞生成素，一种上皮细胞衍生的细胞因子，与哮喘的发病机理有关[1]。 |
| References |
| No Any Chemical & Physical Properties |